Benjamin Edwards Inc Heron Therapeutics, Inc. Transaction History

Benjamin Edwards Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$1.71 - $3.06 $309 - $553	181 Added 22.1%	1,000 $3,000
Q4 2023 Feb 06, 2024	SELL	$0.54 - $1.82 $387 - $1,306	-718 Reduced 46.71%	819 $1,000
Q2 2023 Aug 15, 2023	SELL	$1.11 - $2.88 $209 - $544	-189 Reduced 10.95%	1,537 $2,000
Q1 2023 Apr 27, 2023	SELL	$1.51 - $3.25 $523 - $1,127	-347 Reduced 16.74%	1,726 $3,000
Q2 2022 Aug 12, 2022	BUY	$2.3 - $6.29 $1,329 - $3,635	578 Added 38.66%	2,073 $6,000
Q1 2022 May 04, 2022	BUY	$4.63 - $9.94 $5,806 - $12,464	1,254 Added 520.33%	1,495 $9,000
Q4 2021 Feb 07, 2022	BUY	$8.35 - $12.6 $2,012 - $3,036	241 New	241 $2,000

179

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

Stay updated on Benjamin Edwards Inc with notifications on news.